IBDEI0HB ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8411,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,8411,1,4,0)
 ;;=4^190.7
 ;;^UTILITY(U,$J,358.3,8411,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,8412,0)
 ;;=202.81^^58^609^61
 ;;^UTILITY(U,$J,358.3,8412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8412,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,8412,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,8412,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,8413,0)
 ;;=215.9^^58^609^85
 ;;^UTILITY(U,$J,358.3,8413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8413,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,8413,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,8413,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,8414,0)
 ;;=224.2^^58^609^51
 ;;^UTILITY(U,$J,358.3,8414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8414,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,8414,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,8414,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,8415,0)
 ;;=224.5^^58^609^96
 ;;^UTILITY(U,$J,358.3,8415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8415,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,8415,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,8415,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,8416,0)
 ;;=224.7^^58^609^28
 ;;^UTILITY(U,$J,358.3,8416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8416,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,8416,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,8416,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,8417,0)
 ;;=237.70^^58^609^66
 ;;^UTILITY(U,$J,358.3,8417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8417,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,8417,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,8417,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,8418,0)
 ;;=239.6^^58^609^65
 ;;^UTILITY(U,$J,358.3,8418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8418,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,8418,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,8418,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,8419,0)
 ;;=239.81^^58^609^97
 ;;^UTILITY(U,$J,358.3,8419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8419,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,8419,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,8419,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,8420,0)
 ;;=272.0^^58^609^48
 ;;^UTILITY(U,$J,358.3,8420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8420,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,8420,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,8420,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,8421,0)
 ;;=340.^^58^609^63
 ;;^UTILITY(U,$J,358.3,8421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8421,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,8421,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,8421,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,8422,0)
 ;;=345.90^^58^609^29
 ;;^UTILITY(U,$J,358.3,8422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8422,1,3,0)
 ;;=3^Epliepsy,Unspec
 ;;^UTILITY(U,$J,358.3,8422,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,8422,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,8423,0)
 ;;=368.02^^58^609^23
 ;;^UTILITY(U,$J,358.3,8423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8423,1,3,0)
 ;;=3^Deprivation Amblyopia
 ;;^UTILITY(U,$J,358.3,8423,1,4,0)
 ;;=4^368.02
 ;;^UTILITY(U,$J,358.3,8423,2)
 ;;=^265361
 ;;^UTILITY(U,$J,358.3,8424,0)
 ;;=368.11^^58^609^103
 ;;^UTILITY(U,$J,358.3,8424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8424,1,3,0)
 ;;=3^Sudden Visual Loss
 ;;^UTILITY(U,$J,358.3,8424,1,4,0)
 ;;=4^368.11
 ;;^UTILITY(U,$J,358.3,8424,2)
 ;;=^268831
